Look at Societal Values of Medicines in Pricing: Japan Pharma Industry Chief

March 12, 2019
JPMA President Joji Nakayama The Japan Pharmaceutical Manufacturers Association (JPMA) will work hard to call on the government to look at not only medical values but also societal values offered by medicines when it sets drug prices, President Joji Nakayama...read more